Metsera

Metsera EBITDA per Share

Delisted

The EBITDA per Share of Metsera (MTSR) as of Nov 4, 2026 is -2.18 USD. In the previous year, EBITDA per Share was -0.87 USD — a change of 149.57% (lower).

EBITDA per Share

-2.18USD

YoY

149.57%

Last updated:

EBITDA per Share of Metsera is 2024 -2.18 USD. EBITDA per Share of Metsera was 2023 -0.87 USD. It decreases by 149.57% lower compared to the previous year.

The Metsera EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2022
-0.01 USD
Jan 1, 2023
-0.87 USD
Jan 1, 2024
-2.18 USD
The Metsera EBITDA per Share history
YEAREBITDA per ShareYoY
-2.18USD+149.57%
-0.87USD+6,447.07%
-0.01USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

EBITDA per Share of Metsera is -2.18 USD in 2024.

EBITDA per Share of Metsera changed from -0.87 USD to -2.18 USD, representing a 149.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Metsera since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Metsera

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Metsera